| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.05 | 0.3 |